We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
2026
Dianthus Therapeutics
DNTH
$6.18B
$60.6K ﹤0.01%
+2,342
New +$56.3K
PLRX icon
2027
Pliant Therapeutics
PLRX
$65.6M
$60.4K ﹤0.01%
5,614
– –
ASIX icon
2028
AdvanSix
ASIX
$455M
$60.3K ﹤0.01%
2,633
– –
AAMI
2029
Acadian Asset Management
AAMI
$3.28B
$60K ﹤0.01%
2,708
-530
-16% -$12K
SRDX
2030
DELISTED
Surmodics
SRDX
$59.9K ﹤0.01%
1,426
– –
EU
2031
enCore Energy
EU
$233M
$59.9K ﹤0.01%
15,193
– –
FPX icon
2032
First Trust US Equity Opportunities ETF
FPX
$1.57B
$59.7K ﹤0.01%
601
– –
NN icon
2033
NextNav
NN
$3.27B
$59.6K ﹤0.01%
7,350
+1,858
+34% +$14.7K
TVTX icon
2034
Travere Therapeutics
TVTX
$5.73B
$59.5K ﹤0.01%
7,238
– –
PETQ
2035
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$59.5K ﹤0.01%
2,696
– –
AMPL icon
2036
Amplitude
AMPL
$1.65B
$59.5K ﹤0.01%
6,680
– –
CHCT
2037
Community Healthcare Trust
CHCT
$437M
$59.4K ﹤0.01%
2,538
– –
SWI
2038
DELISTED
SolarWinds Corporation Common Stock
SWI
$59.2K ﹤0.01%
5,026
– –
LQDA icon
2039
Liquidia Corp
LQDA
$6.65B
$59K ﹤0.01%
4,913
– –
PGF icon
2040
Invesco Financial Preferred ETF
PGF
$668M
$58.9K ﹤0.01%
3,996
-1,081
-21% -$16K
OSG
2041
Octave Specialty Group
OSG
$215M
$58.8K ﹤0.01%
4,583
– –
EOLS icon
2042
Evolus
EOLS
$532M
$58.8K ﹤0.01%
5,415
+1,331
+33% +$16.4K
AMTB icon
2043
Amerant Bancorp
AMTB
$1.15B
$58.7K ﹤0.01%
2,588
– –
TK icon
2044
Teekay
TK
$1.09B
$58.7K ﹤0.01%
6,546
– –
BBBY
2045
Bed Bath & Beyond
BBBY
$421M
$58.7K ﹤0.01%
4,932
– –
VTS icon
2046
Vitesse Energy
VTS
$685M
$58.6K ﹤0.01%
2,473
– –
FJAN icon
2047
FT Vest US Equity Buffer ETF January
FJAN
$1.46B
$58.6K ﹤0.01%
1,350
-60
-4% -$2.54K
RLAY icon
2048
Relay Therapeutics
RLAY
$4.32B
$58.5K ﹤0.01%
8,970
– –
SMP icon
2049
Standard Motor Products
SMP
$874M
$58.3K ﹤0.01%
2,104
– –
DXPE icon
2050
DXP Enterprises
DXPE
$3.01B
$58.3K ﹤0.01%
1,272
– –
80 81
82
83 84

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.